DRUG · Unmapped registry intervention
amifostine trihydrate
Find medicine records ·
Find other trials using this name
Clinical trial
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00004264
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
cisplatin
Normalized identity: cisplatinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDocetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Drug/Agent Toxicity by Tissue/Organunresolved
Lung Cancerverified · MONDO: lung cancer
Interventions
cisplatinDRUG · verified · RxNorm: cisplatin
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
University of Wisconsin, Madisonlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00004264 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.